» Articles » PMID: 30778355

Salivary PGE Modulates the Dendritic Cell- Interactions and

Abstract

is an important vector of , causative agent of Rocky Mountain spotted fever and the most lethal tick-borne pathogen affecting humans. To feed on the vertebrate host's blood, secretes a salivary mixture, which may interact with skin resident dendritic cells (DCs) and modulate their function. The present work was aimed at depicting the saliva-host DC network and the biochemical nature of the immunomodulatory component(s) involved in this interface. saliva inhibits the production of inflammatory cytokines by murine DCs stimulated with LPS. The fractionation of the low molecular weight salivary content by reversed-phase chromatography revealed active fractions eluting from 49 to 55% of the acetonitrile gradient. Previous studies suggested that this pattern of elution matches with that observed for prostaglandin E (PGE) and the molecular identity of this lipid mediator was unambiguously confirmed by a new high-resolution mass spectrometry methodology. A productive infection of murine DCs by was demonstrated for the first time leading to proinflammatory cytokine production that was inhibited by both saliva and PGE, a result also achieved with human DCs. The adoptive transfer of murine DCs incubated with followed by treatment with saliva or PGE did not change the cytokine profile associated to cellular recall responses while IgG2a-specific antibodies were decreased in the serum of these mice. Together, these findings emphasize the role of PGE as a universal immunomodulator of tick saliva. In addition, it contributes to new approaches to explore -DC interactions both and .

Citing Articles

Circulating oxidative stress and acute phase protein levels in horses infested with ticks.

Nogueira B, Ortega Orozco A, Argumedo A, de Oliveira Faustino A, Oliveira L, da Fonseca L Exp Appl Acarol. 2023; 90(1-2):155-168.

PMID: 37285109 DOI: 10.1007/s10493-023-00798-z.


-Host-Tick Interactions: Knowledge Advances and Gaps.

Kim H Infect Immun. 2022; 90(9):e0062121.

PMID: 35993770 PMC: 9476906. DOI: 10.1128/iai.00621-21.


Unpacking the intricacies of Rickettsia-vector interactions.

Laukaitis H, Macaluso K Trends Parasitol. 2021; 37(8):734-746.

PMID: 34162522 PMC: 8344978. DOI: 10.1016/j.pt.2021.05.008.


Virulence potential of Rickettsia amblyommatis for spotted fever pathogenesis in mice.

Yen W, Stern K, Mishra S, Helminiak L, Sanchez-Vicente S, Kim H Pathog Dis. 2021; 79(5).

PMID: 33908603 PMC: 8110513. DOI: 10.1093/femspd/ftab024.


Roles of three putative salmon louse (Lepeophtheirus salmonis) prostaglandin E synthases in physiology and host-parasite interactions.

Dalvin S, Eichner C, Dondrup M, Overgard A Parasit Vectors. 2021; 14(1):206.

PMID: 33874988 PMC: 8056522. DOI: 10.1186/s13071-021-04690-w.


References
1.
Konik P, Slavikova V, Salat J, Reznickova J, Dvoroznakova E, Kopecky J . Anti-tumour necrosis factor-alpha activity in Ixodes ricinus saliva. Parasite Immunol. 2006; 28(12):649-56. DOI: 10.1111/j.1365-3024.2006.00899.x. View

2.
Coffman R, OHara J, Bond M, Carty J, Zlotnik A, Paul W . B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol. 1986; 136(12):4538-41. View

3.
Nava S, Beati L, Labruna M, Caceres A, Mangold A, Guglielmone A . Reassessment of the taxonomic status of Amblyomma cajennense () with the description of three new species, Amblyomma tonelliae n. sp., Amblyomma interandinum n. sp. and Amblyomma patinoi n. sp., and reinstatement of Amblyomma mixtum, and Amblyomma.... Ticks Tick Borne Dis. 2014; 5(3):252-76. DOI: 10.1016/j.ttbdis.2013.11.004. View

4.
Jordan J, Woods M, Feng H, Soong L, Walker D . Rickettsiae-stimulated dendritic cells mediate protection against lethal rickettsial challenge in an animal model of spotted fever rickettsiosis. J Infect Dis. 2007; 196(4):629-38. DOI: 10.1086/519686. View

5.
Wang P, Xiong X, Jiao J, Yang X, Jiang Y, Wen B . Th1 epitope peptides induce protective immunity against Rickettsia rickettsii infection in C3H/HeN mice. Vaccine. 2017; 35(51):7204-7212. DOI: 10.1016/j.vaccine.2017.09.068. View